Role of interleukin-1β during pain and inflammation

The cytokine cascade in pain and inflammatory processes is a tremendously complex system, involving glial, immune, and neuronal cell interactions. IL-1beta is a pro-inflammatory cytokine that has been implicated in pain, inflammation and autoimmune conditions. This review will focus on studies that shed light on the critical role of IL-1beta in various pain states, including the role of the intracellular complex, the inflammasome, which regulates IL-1beta production. Evidence will be presented demonstrating the importance of IL-1beta in both the induction of pain and in the maintenance of pain in chronic states, such as after nerve injury. Additionally, the involvement of IL-1beta as a key mediator in the interaction between glia and neurons in pain states will be discussed. Taken together, the evidence presented in the current review showing the importance of IL-1beta in animal and human pain states, suggests that blockade of IL-1beta be considered as a therapeutic opportunity.

[1]  S. Maier,et al.  Characterization of cytokine-induced hyperalgesia , 1994, Brain Research.

[2]  N. Morioka,et al.  Interleukin‐1β Induces Substance P Release from Primary Afferent Neurons Through the Cyclooxygenase‐2 System , 1999, Journal of neurochemistry.

[3]  P. Anand,et al.  Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain , 2005, Pain.

[4]  L. Sorkin,et al.  Effect of cytokines on neuronal excitability , 2008, Neuroscience Letters.

[5]  C. Woolf,et al.  The neuropathic pain triad: neurons, immune cells and glia , 2007, Nature Neuroscience.

[6]  P. Hawkins,et al.  Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. , 2004, Arthritis and rheumatism.

[7]  C. Sommer,et al.  Cytokine regulation in animal models of neuropathic pain and in human diseases , 2008, Neuroscience Letters.

[8]  G. Yancopoulos,et al.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. , 2008, Arthritis and rheumatism.

[9]  S. McMahon,et al.  Pathophysiology of Peripheral Neuropathic Pain: Immune Cells and Molecules , 2007, Anesthesia and analgesia.

[10]  S. Malawista,et al.  Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. , 1987, Journal of immunology.

[11]  S. Jabbur,et al.  The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation , 2002, Neuropharmacology.

[12]  Steven F. Maier,et al.  Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states , 1995, Pain.

[13]  Scott Carver,et al.  Cytokine traps: multi-component, high-affinity blockers of cytokine action , 2003, Nature Medicine.

[14]  L. Schlichter,et al.  Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment , 2007, Brain Research.

[15]  F. Martinon,et al.  Inflammatory caspases and inflammasomes: master switches of inflammation , 2007, Cell Death and Differentiation.

[16]  E. Costa,et al.  Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes. , 1991, Molecular pharmacology.

[17]  S. Aou,et al.  Intracerebroventricular injection of interleukin-1β induces hyperalgesia in rats , 1993, Brain Research.

[18]  S. Maier,et al.  Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. , 2003, Advances in experimental medicine and biology.

[19]  D. Kastner,et al.  The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations , 2003, Current opinion in rheumatology.

[20]  C. Sommer,et al.  Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain , 2007, Brain, Behavior, and Immunity.

[21]  T. Olsson,et al.  Cytokine responses during chronic denervation , 2005, Journal of Neuroinflammation.

[22]  R. Terkeltaub.  Gout in 2006: the perfect storm. , 2006, Bulletin of the NYU hospital for joint diseases.

[23]  M. Avilés-Trigueros,et al.  Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1α and interleukin-1β in Wallerian degeneration , 2005 .

[24]  G. Cook,et al.  Primer: inflammasomes and interleukin 1β in inflammatory disorders , 2008, Nature Clinical Practice Rheumatology.

[25]  W. Guo,et al.  Tyrosine Phosphorylation of the NR2B Subunit of the NMDA Receptor in the Spinal Cord during the Development and Maintenance of Inflammatory Hyperalgesia , 2002, The Journal of Neuroscience.

[26]  J. Tschopp,et al.  A pilot study of IL-1 inhibition by anakinra in acute gout , 2007, Arthritis research & therapy.

[27]  R. Ransohoff,et al.  Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses , 2007, Neuroscience.

[28]  Wei Guo,et al.  Antibody array analysis of peripheral and blood cytokine levels in rats after masseter inflammation , 2005, Neuroscience Letters.

[29]  R. Liu-Bryan,et al.  Overview of hyperuricaemia and gout. , 2005, Current pharmaceutical design.

[30]  C L Galli,et al.  Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases , 2003, The Journal of Neuroscience.

[31]  R. Huganir,et al.  Characterization of Protein Kinase A and Protein Kinase C Phosphorylation of the N-Methyl-D-aspartate Receptor NR1 Subunit Using Phosphorylation Site-specific Antibodies* , 1997, The Journal of Biological Chemistry.

[32]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[33]  J. Deleo,et al.  Complete Freunds adjuvant‐induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS , 2004, The European journal of neuroscience.

[34]  S. Mariathasan,et al.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation , 2007, Nature Reviews Immunology.

[35]  R. Dubner,et al.  Trigeminal transition zone/rostral ventromedial medulla connections and facilitation of orofacial hyperalgesia after masseter inflammation in rats , 2005, The Journal of comparative neurology.

[36]  S. Maier,et al.  Intrathecal HIV-1 Envelope Glycoprotein gp120 Induces Enhanced Pain States Mediated by Spinal Cord Proinflammatory Cytokines , 2001, The Journal of Neuroscience.

[37]  N. Dalbeth,et al.  Mechanisms of inflammation in gout. , 2005, Rheumatology.

[38]  Xian-Min Yu,et al.  NMDA Channel Regulation by Channel-Associated Protein Tyrosine Kinase Src , 1997, Science.

[39]  C. Woolf,et al.  Neuronal plasticity: increasing the gain in pain. , 2000, Science.

[40]  A. Freemont,et al.  Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1β and TNFα expression profile , 2007, Arthritis research & therapy.

[41]  C. Sommer,et al.  Intraneural injection of interleukin-1β and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain , 2005, Pain.

[42]  Adam Sapirstein,et al.  Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity , 2001, Nature.

[43]  S. Rotshenker,et al.  The Cytokine Network of Wallerian Degeneration: Tumor Necrosis Factor-α, Interleukin-1α, and Interleukin-1β , 2002, The Journal of Neuroscience.

[44]  M. Kawatani,et al.  Cutaneous hyperalgesia induced by peripheral injection of interleukin-1β in the rat , 1994, Brain Research.

[45]  D. Kastner,et al.  Familial autoinflammatory diseases: genetics, pathogenesis and treatment , 2005, Current opinion in rheumatology.

[46]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[47]  S. Maier,et al.  GLIA: A novel drug discovery target for clinical pain , 2003, Nature Reviews Drug Discovery.

[48]  D. Kastner,et al.  A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. , 2008, Arthritis and rheumatism.

[49]  S. Akira,et al.  MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. , 2006, The Journal of clinical investigation.

[50]  C. Woolf,et al.  Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC‐dependent site, serine‐896, in spinal cord dorsal horn neurons , 2004, The European journal of neuroscience.

[51]  A. Reeve,et al.  Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat , 2000, European journal of pain.

[52]  R. Yezierski,et al.  The role of neuroinflammation and neuroimmune activation in persistent pain , 2001, Pain.

[53]  A. Light,et al.  Translational pain research , 2018, European Journal of Anaesthesiology.

[54]  S. McMahon,et al.  Rapid co‐release of interleukin 1β and caspase 1 in spinal cord inflammation , 2006, Journal of neurochemistry.

[55]  NMDA Receptor Subunits: Function and Pharmacology , 2007 .

[56]  Khaleel Bhaukaurally,et al.  Glutamate exocytosis from astrocytes controls synaptic strength , 2007, Nature Neuroscience.

[57]  Vincenzo Crunelli,et al.  Astrocytes target presynaptic NMDA receptors to give synapses a boost , 2007, Nature Neuroscience.

[58]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[59]  Wen-xia Zhou,et al.  Interleukin-1β enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission , 2005, Brain Research.

[60]  V. Barak,et al.  Interleukin-1 activity in lesioned peripheral nerve , 1992, Journal of Neuroimmunology.

[61]  Li Chen,et al.  Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation , 1992, Nature.

[62]  Y. Shavit,et al.  Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice , 2006, Pain.

[63]  C. Sommer,et al.  Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia , 2004, Neuroscience Letters.

[64]  C. Sommer,et al.  Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice , 2001, Neuroscience Letters.

[65]  H. Thoenen,et al.  Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve , 1987, Nature.

[66]  A. Martini,et al.  Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. , 2007, Arthritis and rheumatism.

[67]  J. Bauer,et al.  Endotoxin-induced appearance of immunoreactive interleukin-1β in ramified microglia in rat brain: A light and electron microscopic study , 1995, Neuroscience.

[68]  H. Thoenen,et al.  Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. , 1988, The Journal of biological chemistry.

[69]  W. Guo,et al.  Glial–Cytokine–Neuronal Interactions Underlying the Mechanisms of Persistent Pain , 2007, The Journal of Neuroscience.

[70]  S. Ferreira,et al.  Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue , 1988, Nature.

[71]  G. Nuki,et al.  A concise history of gout and hyperuricemia and their treatment , 2006, Arthritis research & therapy.

[72]  H. Boddeke,et al.  Expression of interleukin-1 beta in rat dorsal root ganglia , 2001, Journal of Neuroimmunology.

[73]  J. Deleo,et al.  Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain , 2001, Neuroscience.

[74]  C. Woolf,et al.  Contribution of interleukin‐1β to the inflammation‐induced increase in nerve growth factor levels and inflammatory hyperalgesia , 1995, British journal of pharmacology.

[75]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[76]  G. Firestein,et al.  Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist , 2004, The Lancet.

[77]  M. Kress,et al.  IL‐1J potentiates heat‐activated currents in rat sensory neurons: involvement of IL‐1RI, tyrosine kinase, and protein kinase C , 2002 .

[78]  M. Kress,et al.  Involvement of the Proinflammatory Cytokines Tumor Necrosis Factor-α, IL-1β, and IL-6 But Not IL-8 in the Development of Heat Hyperalgesia: Effects on Heat-Evoked Calcitonin Gene-Related Peptide Release from Rat Skin , 2000, The Journal of Neuroscience.

[79]  C. Sommer,et al.  Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy , 1999, Neuroscience Letters.

[80]  M. Iadarola,et al.  Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation , 2005, Molecular pain.

[81]  S. Aou,et al.  Intracerebroventricular injection of interleukin-1β enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats , 1994, Brain Research.

[82]  W. Willis,et al.  Role of protein kinase A in phosphorylation of NMDA receptor 1 subunits in dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats , 2002, Neuroscience.

[83]  F. Martinon,et al.  NALPs: a novel protein family involved in inflammation , 2003, Nature Reviews Molecular Cell Biology.

[84]  C. Woolf,et al.  Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor α , 1997, British journal of pharmacology.

[85]  Martin Braddock,et al.  Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention , 2004, Nature Reviews Drug Discovery.

[86]  Clifford J. Woolf,et al.  Neuronal Plasticity and Signal Transduction in Nociceptive Neurons: Implications for the Initiation and Maintenance of Pathological Pain , 2001, Neurobiology of Disease.

[87]  F. Cunha,et al.  Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐1 receptor antagonist , 2000, British journal of pharmacology.

[88]  J. Weinstein,et al.  Spinal glial activation and cytokine expression after lumbar root injury in the rat. , 2000, Spine.

[89]  S. Malawista,et al.  Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. , 1985, Arthritis and rheumatism.

[90]  R. Ji,et al.  Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord , 2008, The Journal of Neuroscience.

[91]  L. Lao,et al.  Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia , 2005, Pain.

[92]  Ping-Heng Tan,et al.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain , 2008, Nature Medicine.

[93]  Aihui Li,et al.  IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats , 2008, PAIN.

[94]  H. Lee,et al.  Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model , 2004, Neuroreport.

[95]  R. Kolodner,et al.  Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome , 2001, Nature Genetics.

[96]  C. Dinarello.  Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. , 2004, Current opinion in pharmacology.